Emerging therapeutic potential of whey proteins and peptides

Current Pharmaceutical Design

Volumn 12, Issue 13, 2006, Pages 1637-1643

  Suha Yalcin A ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

lactalbumin; lactoglobulin; Bioactive peptide; Immunoglobulin; Lactoferrin; Whey proteins

Indexed keywords

ALPHA LACTALBUMIN; ALPHA LACTORPHIN; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; BETA 2 MICROGLOBULIN; BETA CASEIN; BETA LACTOGLOBULIN; CALCIUM; CASEIN; CASOKININ DERIVATIVE; CASOMORPHIN DERIVATIVE; CASOXIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE; ESSENTIAL AMINO ACID; GLYCOPROTEIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOPEPTIDE DERIVATIVE; LACTOFERRICIN; LACTOFERRIN; LACTOFERROXIN DERIVATIVE; LACTOPEROXIDASE; LYSOZYME; MILK PROTEIN; OPIATE AGONIST; PEPTIDE DERIVATIVE; SERUM ALBUMIN; SOMATOMEDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D;

AMINO ACID ANALYSIS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ANXIETY; ARTIFICIAL MILK; CANCER PREVENTION; COMMERCIAL PHENOMENA; DEPRESSION; DIET SUPPLEMENTATION; DRUG MECHANISM; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; FOOD HANDLING; FOOD PROCESSING; GASTROINTESTINAL TRACT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; REVIEW; SPORTS DRINK; STRESS;

ANTI-BACTERIAL AGENTS; HIV INFECTIONS; HUMANS; IMMUNITY; LACTALBUMIN; LACTOFERRIN; LACTOGLOBULINS; MILK PROTEINS; ORAL HEALTH; OXIDATIVE STRESS;

EID: 33646515568     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206776843296     Document Type: Review

References (72)

1. Reference Manual for US Whey and Lactose Products, U.S. Dairy Export Council, 2001; http://www.usdec.org/publications/ PubDetail.cfm?ItemNumber=587.
2. Hoffman JR, Falvo MJ. Protein-which is best? J Sport Sci Med 2004; 3: 118-30.
3. Boine Y, Dangin M, Gachon P, Vasson MP, Maubois JL, Beaufrere B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Procl Natl Acad Sci USA 1997; 94: 14930-5.
4. Huffman L, Harper WJ. Maximizing the value of milk through separation techniques. J Dairy Sci 1999; 82: 2238-44.
5. Etzel MR. Manufacture and use of dairy protein fractions. J Nutr 2004; 134: 996-1002.
6. Smithers GW, Ballard FJ, Copeland AD, De Silva KJ, Dionysius DA, Francis GL, et al. New opportunities from the isolation and utilization of whey proteins. J Dairy Sci 1996; 79: 1454-9.
7. Horton BS. Commercial utilization of minor milk components in the health and food industries. J Dairy Sci 1995; 78: 2584-9.
8. Steijns JM. Milk ingredients as nutraceuticals. Int J Dairy Tech 2001; 54: 81-88.
9. Jensen RG. Handbook of Milk Composition. Academic Press, San Diego 1995.
10. Fox PF, Flynn A. In: Fox PF Ed, Biological properties of milk proteins. Advanced Dairy Chemistry. Elsevier, London 1992; Vol. 1: 255-84.
11. Korhonen H, Pihlanto-Leppala A, Rantamaki P, Tupasela T. Impact of processing on bioactive proteins and peptides. Trends Food Sci Technol 1998; 9: 307-19.
12. Pihlanto A, Korhonen H. In: Taylor SL Ed, Bioactive peptides and proteins. Advances in Food and Nutrition Research, Elsevier, San Diego 2003; 47: 175-276.
13. Abd El Salam MH, El-Shibiny S, Buchheim W. Characteristics and potential uses of the casein macropeptide. Int Dairy J 1996; 6: 327-41.
14. Brody EP. Biological activities of bovine glycomacropeptide. Br J Nutr 2000; 84: S39-49.
15. Reiter B, Harnulv G. Lactoperoxidase antibacterial system: natural occurence, biological functions and practical applications. J Food Prot 1984; 47: 724-32.
16. Lonnerdal B, Iyer S. Lactoferrin: molecular structure and biological function. Ann Rev Nutr 1995; 15: 93-110.
17. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995; 80: 252-67.
18. Meisel H. Bioactive peptides from milk proteins: a perspective for consumers and producers. Aust J Dairy Tech 2001; 56: 83-92.
19. Clare DA, Swaisgood HE. Bioactive milk peptides: a prospectus. J Dairy Sci 2000; 83: 1187-95.
20. Korhonen H, Pihlanto A. Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 2003; 9: 1297-308.
21. Jenness R. In: Fox PF Ed, Interspecies comparison of milk proteins. Developments in Dairy Chemistry. Appl Sci Pub, New York, 1982; 87-114.
22. Jost R, Maire J-C, Maynard F, Secretin M-C. Aspects of whey protein usage in infant nutrition, a brief review. Int J Food Sci Technol 1999; 34: 533-42.
23. Roitt I, Brostoff J, Male D. Immunology. Churchill Livingstone, London 1985.
24. Cross ML, Gill HS. Immunomodulatory properties of milk. Br J Nutr 2000; 84: 81-9.
25. Gill HS, Doull F, Cross ML. Immunoregulatory peptides in milk. Br J Nutr 2000; 84: 111-7.
26. Kilara A, Panyam D. Peptides from milk proteins and their properties. Crit Rev Food Sci Nutr 2003; 43: 607-33.
27. Björck L, Hopkin E. Significance of the indigenous antimicrobial agents of milk to the dairy industry. Bull Int Dairy Fed 1991; 246: 1-19.
28. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J Nutr 1995; 125: 1238-44.
29. Reiter B. Protective proteins in milk- biological significance and exploitation. Bull Int Dairy Fed 1985; 191: 1-35.
30. Goldman AS. Immunologic supplementation of cow's milk formulations. Bull Int Dairy Fed 1989; 244: 38-43.
31. Weiner C, Pan Q, Hurtig M, Boren T, Bostwick E, Hammarström L. Passive immunity against human pathogens using bovine antibodies. Clin Exp Immunol 1999; 116: 193-205.
32. Korhonen H, Marnila P, Gill S. Bovine milk antibodies for health. Br J Nutr 2000; 84(Suppl 1): S135-S146.
33. Uruakpa FO, Ismond MAH, Akobundu ENT. Colostrum and its benefits: a review. Nutr Res 2002; 22: 755-67.
34. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 2nd Ed, Clarendon Press, Oxford 1989.
35. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1977; 197: 263-5.
36. Kuipers ME, de Vries-Hospers HG, Eikelboom MC, Meijer DKF, Swart PJ. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicr Agent Chemother 1999; 43: 2635-41.
37. Van der Strate BWA, Beljaars L, Molema G, Harmsen MC, Meijer DKF. Antiviral activities of lactoferrin. Antiviral Res 2001; 52: 225-239.
38. Wakayabashi H, Takase M, Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr Pharm Des 2003; 9: 1277-87.
39. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988; 263: 17205-8.
40. Bounous G, Letourneau L, Kongshavn PAL. Influence of dietary protein type on the immune system of mice. J Nutr 1983; 113: 1415-21.
41. Bounous G, Gold P. The biological activity of undenatured dietary whey proteins: role of glutathione. Clin Invest Med 1991; 14: 296-309.
42. Kent KD, Harper WJ, Bomser JA. Effect of whey protein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epithelial cells. Toxicol In vitro 2003; 17: 27-33.
43. Bouthegourd J-C J, Roseau SM, Makarios-Lanham L, Leruyet PM, Tome DG, Even PC. A preexercise α-lactalbumin-enriched whey protein meal preserves lipid oxidation and decreases adiposity in rats. Am J Physiol Endocrinol Metab 2002; 46: E565-72.
44. Zommara M, Tachibana N, Sakono M, Suzuki Y, Oda T, Hashiba H, et al. Whey from cultured skim milk decreases serum cholesterol and increases antioxidant enzymes in liver and red blood cells in rats. Nutrition Res 1996; 16: 293-302.
45. Velioǧlu-Öǧünç A, Manukyan M, Cingi A, Aktan AÖ, Yalçin AS. The effect of dietary whey supplementation on wound healing, Med J Kocatepe 2003; S: 51-54.
46. Legrand-Poels S, Vaira D, Pincemail J, van de Vorst A, Piette J. Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retrovir 1990; 6: 1389-97.
47. Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, Saltini C, et al. Systemic glutathione deficiency in symptom-free HIV seropositive individuals. Lancet 1989; 2: 1294-8.
48. Staal FJ. Glutathione and HIV infection: reduced reduced, or increased oxidized? Eur J Clin Invest 1998; 28: 194-6.
49. Bounous G, Baruchel S, Falutz J, Gold P. Whey proteins as a food supplement in HIV-seropositive individuals. Clin Invest Med 1993; 16: 204-9.
50. Micke P, Beeh KM, Schlaak JF, Buhl R. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest 2001; 31: 171-8.
51. Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr 2002; 41: 12-8.
52. Food, Nutrition and Cancer: a global perspective. World Cancer Research Fund and American Institute for Cancer Research 1997.
53. Gill HS, Cross ML. Anticancer properties of bovine milk. Brit J Nutr 2000; 84: S161-6.
54. Tsai WY, Chang W-H, Chen C-H, Lu F-J. Enhancing effect of patented whey protein isolate (Immunocal) on cytotoxicity of an anticancer drug. Nutr Canc 2000; 30: 200-8.
55. Bounous G, Batist G, Gold P. Whey proteins in cancer prevention. Cancer Lett 1991; 57: 91-4.
56. Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res 2000; 20: 4785-92.
57. Stanford SC. In: Stanford SC, Salmon P Eds, Monoamines in response and adaptation to stress. Stress: from Synapse to Syndrome. London, Academic Press 1993; 24-30.
58. Markus CR, Olivier B, de Haan EHF. Whey protein rich in alactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr 2002; 75: 1051-6.
59. Nederfors T. Xerostomia and hyposalivation. Adv Dent Res 2000; 14: 48-56.
60. Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 2002; 8: 23-9.
61. Warner EA, Kanekanian AD, Andrews AT. Bioactivity of milk proteins: 1. Anticariogenicity of whey proteins. Int J Dairy Technol 2001; 54: 151-3.
62. Causey J, Thomson K. The whey to intestinal health. Today's Dietitian 2003; July: 22-25. http://www.wheyoflife.org/news/WheyFeature.pdf
63. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microflora: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
64. Petschow BW, Talbott RD. Growth promotion of Bifidobacterium species by whey and casein fractions from human and bovine milk. J Clin Microbiol 1990; 28: 287-92.
65. Harper WJ. Biological properties of whey components: a review. The American Dairy Products Institute, Chicago, 2000.
66. Warny M, Fatima A, Bostwick EF, et al. Bovine immunoglobulin concentrate -Clostridium difficile retains C. difficile toxin neutralizing activity after passage through the human stomach and small intestine. Gut 1999; 44: 212-7.
67. Kilara A, Panyam D. Peptides from milk proteins and their properties. Crit Rev Food Sci Nutr 2003; 43: 607-33.
68. Dionysius DA, Milne JM. Antibacterial peptides of bovine lactoferrin: purification and characterization. J Dairy Sci 1997; 80: 667-74.
69. Pihlanto-Leppala A. Bioactive peptides from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends Food Sci Technol 2000; 11: 347-56.
70. Florisa R, Recio I, Berkhout B, Visser S. Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr Pharm Des 2003; 9(16): 1257-75.
71. Kitts DD, Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm Des 2003; 9(16): 1309-23.
72. Korhonen H, Pihlanto A. Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 2003; 9(16): 1297-308.